Drug use is fueling record-high syphilis rates around the nation, a CDC report said; the Fifth Circuit Court of Appeals is allowing House Democrats to defend the Affordable Care Act (ACA) in a lawsuit that challenges the law’s constitutionality; the World Health Organization (WHO) is convening an expert meeting in March to develop global standards for the governance and oversight of human gene editing.
Drug use is fueling record-high syphilis rates around the nation, a CDC report said. The report shows a large intersection between drug use and syphilis among women and heterosexual men. In those groups, reported use of methamphetamine, heroin, and other injection drugs more than doubled from 2013 to 2017, Kaiser Health News reported.
The Fifth Circuit Court of Appeals is allowing House Democrats to defend the Affordable Care Act in a lawsuit that challenges the law’s constitutionality, Politico reported. Democrats voted last month to intervene in the lawsuit. The court also approved requests from 4 states (Colorado, Iowa, Michigan, and Nevada) to join the defense being mounted by a list of blue states.
The World Health Organization is convening an expert meeting in March to develop global standards for the governance and oversight of human gene editing, the Associated Press reported. The panel will examine the scientific, ethical, social, and legal challenges. Last fall, Chinese researcher He Jiankui claimed he altered the DNA of twin girls to make them resistant to HIV, in a move criticized by many scientists.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen